Phylogica Limited

ASX:PYC ISIN:AU000000PYC7

Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.  
 
        

Lihat di Bahasa Lain

Berita

Laporan Pasar Australia 20 Desember 2010: IMX Resources (ASX:IXR) Meluncurkan Pengapalan Pertama Biji Tembaga Besinya ke Cina

🕔12/20/2010 1:30:00 PM 12888

Laporan Pasar Australia 20 Desember 2010 memuat: IMX Resources Limited (ASX:IXR) telah meluncurkan pengapalan pertamanya untuk biji tembaga besi ke Cina; Phylogica Limited (ASX:PYC) menanda tangani perjanjian kolaborasi danlisensi dengan Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) menerima hasil yang kuat untuk tembaga, perak, kobalt di Walford Creek, Queensland Baratlaut; Produksi biji besi South American Ferro Metals Limited (ASX:SFZ) di Brazil melampaui 400.000 ton.

Baca Full Story▸
###

82,610 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 16) (30 Hari Terakhir: 85) (Sejak Ditampilkan: 8622) 

Data Perusahaan

    Fax
  • 08 9423 8899 
    • Sektor Utama
  • Kesehatan & Pharm 
    • Industri Utama
  • Biotechnology 
    • Homepage
  • www.phylogica.com/

Lebih banyak Berita lagi

  • 2024/07/22: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/07/17: Initial Dosing Completed in Cohort 1 of RP11 MAD Study*
  • 2024/07/12: Bioshares Biotech Summit Presentation*
  • 2024/07/10: Commencement of RP11 Multiple Dose Trial*
  • 2024/07/02: Notification regarding unquoted securities - PYC*
  • 2024/07/01: RP11 Drug Candidate Safe and Well Tolerated*
  • 2024/06/07: PMS Drug Candidate Effective In Human Brain Cells*
  • 2024/05/24: US FDA Grants Orphan Drug Designation to PYC Drug Candidate*
  • 2024/05/24: Small Shareholdings Sale Facility*
  • 2024/05/23: Issue of Options*
*refer to company website